Asia Pacific Companion Diagnostics Market (2019-2025)
The Asia Pacific Companion Diagnostics Market would witness market growth of 21.6% CAGR during the forecast period (2019-2025).
A number of businesses have conducted projects to create biomarker-based therapeutics for other signs of illnesses, including infectious conditions, neurology, and metabolic disorders. Stakeholders in the industry are crafting strategic alliances with the development of diagnostic alternatives for a range of drugs/therapies. Such initiatives focus on enhancing the success rates of clinical trials, thereafter optimizing research and development expenses in the pharmaceutical sector.
In the forecast period, the Asia-Pacific growth rate is anticipated to be highest, mainly owing to increasing demand for personalized medication, the development of health facilities as well as increasing prevalence of different types of cancer that have more unmet needs. The cost efficiency, high sensitivity, and specificity are several main driving factors for market expansion and can be used in simple automated systems. The PCR, which is another important driver of this section, can also determine the sequencing of unknown disease etiologies of many diseases.
Based on Technology, the market is segmented into Immunohistochemistry, Polymerase chain reaction (PCR), Next generation sequencing (NGS), In Situ Hybridization, and Other Technology. Based on Indication, the market is segmented into Oncology, Neurology and Other Indications. Further based on Cancer Type, the Oncology market is segmented into Breast Cancer, Colorectal Cancer, Lung Cancer, Blood Cancer and Other Cancer Type. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Australia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Agilent Technologies, Inc., Almac Group, ARUP Laboratories, Inc., Abbott Laboratories (Abbott Laboratories Molecular, Inc.), Danaher Corporation, Thermo Fisher Scientific, Inc., Hologic, Inc., Novartis AG, Illumina, Inc., Qiagen N.V.
Scope of the Study
Market Segmentation:
By Technology
A number of businesses have conducted projects to create biomarker-based therapeutics for other signs of illnesses, including infectious conditions, neurology, and metabolic disorders. Stakeholders in the industry are crafting strategic alliances with the development of diagnostic alternatives for a range of drugs/therapies. Such initiatives focus on enhancing the success rates of clinical trials, thereafter optimizing research and development expenses in the pharmaceutical sector.
In the forecast period, the Asia-Pacific growth rate is anticipated to be highest, mainly owing to increasing demand for personalized medication, the development of health facilities as well as increasing prevalence of different types of cancer that have more unmet needs. The cost efficiency, high sensitivity, and specificity are several main driving factors for market expansion and can be used in simple automated systems. The PCR, which is another important driver of this section, can also determine the sequencing of unknown disease etiologies of many diseases.
Based on Technology, the market is segmented into Immunohistochemistry, Polymerase chain reaction (PCR), Next generation sequencing (NGS), In Situ Hybridization, and Other Technology. Based on Indication, the market is segmented into Oncology, Neurology and Other Indications. Further based on Cancer Type, the Oncology market is segmented into Breast Cancer, Colorectal Cancer, Lung Cancer, Blood Cancer and Other Cancer Type. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Australia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Agilent Technologies, Inc., Almac Group, ARUP Laboratories, Inc., Abbott Laboratories (Abbott Laboratories Molecular, Inc.), Danaher Corporation, Thermo Fisher Scientific, Inc., Hologic, Inc., Novartis AG, Illumina, Inc., Qiagen N.V.
Scope of the Study
Market Segmentation:
By Technology
- Immunohistochemistry
- Polymerase chain reaction (PCR)
- Next generation sequencing (NGS)
- In Situ Hybridization and
- Other Technology
- Oncology
- Neurology and
- Other Indications
- Breast Cancer
- Colorectal Cancer
- Lung Cancer
- Blood Cancer and
- Other Cancer Type
- China
- Japan
- India
- South Korea
- Singapore
- Australia
- Rest of Asia Pacific
- Agilent Technologies, Inc.
- Almac Group
- ARUP Laboratories, Inc.
- Abbott Laboratories (Abbott Laboratories Molecular, Inc.)
- Danaher Corporation
- Thermo Fisher Scientific, Inc.
- Hologic, Inc.
- Novartis AG
- Illumina, Inc.
- Qiagen N.V.
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
CHAPTER 1. MARKET SCOPE & METHODOLOGY
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Companion Diagnostics Market, by Technology
1.4.2 Asia Pacific Companion Diagnostics Market, by Indication
1.4.3 Asia Pacific Companion Diagnostics Market, by Cancer Type
1.4.4 Asia Pacific Companion Diagnostics Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Executive Summary
2.1.3 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. ASIA PACIFIC COMPANION DIAGNOSTICS MARKET BY TECHNOLOGY
3.1 Asia Pacific Immunohistochemistry Market by Country
3.2 Asia Pacific Polymerase chain reaction (PCR) Market by Country
3.3 Asia Pacific Next generation sequencing (NGS) Market by Country
3.4 Asia Pacific In Situ Hybridization Market by Country
3.5 Asia Pacific Other Technology Market by Country
CHAPTER 4. ASIA PACIFIC COMPANION DIAGNOSTICS MARKET BY INDICATION
4.1 Asia Pacific Oncology Companion Diagnostics Market by Country
4.1.1 Asia Pacific Companion Diagnostics Market by Cancer Type
4.1.1.1 Asia Pacific Breast Cancer Companion Diagnostics by Country
4.1.1.2 Asia Pacific Colorectal Cancer Companion Diagnostics by Country
4.1.1.3 Asia Pacific Lung Cancer Companion Diagnostics by Country
4.1.1.4 Asia Pacific Blood Cancer Companion Diagnostics by Country
4.1.1.5 Asia Pacific Other Cancer Type Companion Diagnostics Market by Country
4.2 Asia Pacific Neurology Companion Diagnostics Market by Country
4.3 Asia Pacific Other Indications Companion Diagnostics Market by Country
CHAPTER 5. ASIA PACIFIC COMPANION DIAGNOSTICS MARKET BY COUNTRY
5.1 China Companion Diagnostics Market
5.1.1 China Companion Diagnostics Market by Technology
5.1.2 China Companion Diagnostics Market by Indication
5.1.2.1 China Companion Diagnostics Market by Cancer Type
5.2 Japan Companion Diagnostics Market
5.2.1 Japan Companion Diagnostics Market by Technology
5.2.2 Japan Companion Diagnostics Market by Indication
5.2.2.1 Japan Companion Diagnostics Market by Cancer Type
5.3 India Companion Diagnostics Market
5.3.1 India Companion Diagnostics Market by Technology
5.3.2 India Companion Diagnostics Market by Indication
5.3.2.1 India Companion Diagnostics Market by Cancer Type
5.4 Australia Companion Diagnostics Market
5.4.1 Australia Companion Diagnostics Market by Technology
5.4.2 Australia Companion Diagnostics Market by Indication
5.4.2.1 Australia Companion Diagnostics Market by Cancer Type
5.5 South Korea Companion Diagnostics Market
5.5.1 South Korea Companion Diagnostics Market by Technology
5.5.2 South Korea Companion Diagnostics Market by Indication
5.5.2.1 South Korea Companion Diagnostics Market by Cancer Type
5.6 Singapore Companion Diagnostics Market
5.6.1 Singapore Companion Diagnostics Market by Technology
5.6.2 Singapore Companion Diagnostics Market by Indication
5.6.2.1 Singapore Companion Diagnostics Market by Cancer Type
5.7 Rest of Asia Pacific Companion Diagnostics Market
5.7.1 Rest of Asia Pacific Companion Diagnostics Market by Technology
5.7.2 Rest of Asia Pacific Companion Diagnostics Market by Indication
5.7.2.1 Rest of Asia Pacific Companion Diagnostics Market by Cancer Type
CHAPTER 6. COMPANY PROFILES
6.1 Agilent Technologies, Inc.
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 Recent strategies and developments:
6.1.5.1 Product launches:
6.1.5.2 Expansions:
6.2 Almac Group
6.2.1 Company Overview
6.2.1 Recent strategies and developments:
6.2.1.1 Collaborations, partnerships and agreements:
6.3 ARUP Laboratories, Inc.
6.3.1 Company Overview
6.4 Abbott Laboratories (Abbott Laboratories Molecular, Inc.)
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expense
6.5 Danaher Corporation
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental and Regional Analysis
6.5.4 Research & Development Expense
6.5.5 Recent strategies and developments:
6.5.5.1 Acquisition and mergers:
6.6 Thermo Fischer Scientific, Inc.
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expense
6.6.5 Recent strategies and developments:
6.6.5.1 Collaborations, partnerships and agreements:
6.6.5.2 Expansions:
6.7 Hologic, Inc.
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Segmental and Regional Analysis
6.7.4 Research & Development Expense
6.7.5 Recent strategies and developments:
6.7.5.1 Product launches:
6.7.5.2 Acquisition and mergers:
6.8 Novartis AG
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental and Regional Analysis
6.8.4 Research & Development Expense
6.8.5 Recent strategies and developments:
6.8.5.1 Collaborations, partnerships and agreements:
6.9 Illumina, Inc.
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Regional Analysis
6.9.4 Research & Development Expense
6.9.5 Recent strategies and developments:
6.9.5.1 Product launches:
6.9.5.2 Acquisition and mergers:
6.9.5.3 Collaborations, partnerships and agreements:
6.1 Qiagen N.V.
6.10.1 Company Overview
6.10.2 Financial Analysis
6.10.3 Regional Analysis
6.10.4 Research & Development Expense
6.10.5 Recent strategies and developments:
6.10.5.1 Product launches:
6.10.5.2 Collaborations, partnerships and agreements:
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Companion Diagnostics Market, by Technology
1.4.2 Asia Pacific Companion Diagnostics Market, by Indication
1.4.3 Asia Pacific Companion Diagnostics Market, by Cancer Type
1.4.4 Asia Pacific Companion Diagnostics Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Executive Summary
2.1.3 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. ASIA PACIFIC COMPANION DIAGNOSTICS MARKET BY TECHNOLOGY
3.1 Asia Pacific Immunohistochemistry Market by Country
3.2 Asia Pacific Polymerase chain reaction (PCR) Market by Country
3.3 Asia Pacific Next generation sequencing (NGS) Market by Country
3.4 Asia Pacific In Situ Hybridization Market by Country
3.5 Asia Pacific Other Technology Market by Country
CHAPTER 4. ASIA PACIFIC COMPANION DIAGNOSTICS MARKET BY INDICATION
4.1 Asia Pacific Oncology Companion Diagnostics Market by Country
4.1.1 Asia Pacific Companion Diagnostics Market by Cancer Type
4.1.1.1 Asia Pacific Breast Cancer Companion Diagnostics by Country
4.1.1.2 Asia Pacific Colorectal Cancer Companion Diagnostics by Country
4.1.1.3 Asia Pacific Lung Cancer Companion Diagnostics by Country
4.1.1.4 Asia Pacific Blood Cancer Companion Diagnostics by Country
4.1.1.5 Asia Pacific Other Cancer Type Companion Diagnostics Market by Country
4.2 Asia Pacific Neurology Companion Diagnostics Market by Country
4.3 Asia Pacific Other Indications Companion Diagnostics Market by Country
CHAPTER 5. ASIA PACIFIC COMPANION DIAGNOSTICS MARKET BY COUNTRY
5.1 China Companion Diagnostics Market
5.1.1 China Companion Diagnostics Market by Technology
5.1.2 China Companion Diagnostics Market by Indication
5.1.2.1 China Companion Diagnostics Market by Cancer Type
5.2 Japan Companion Diagnostics Market
5.2.1 Japan Companion Diagnostics Market by Technology
5.2.2 Japan Companion Diagnostics Market by Indication
5.2.2.1 Japan Companion Diagnostics Market by Cancer Type
5.3 India Companion Diagnostics Market
5.3.1 India Companion Diagnostics Market by Technology
5.3.2 India Companion Diagnostics Market by Indication
5.3.2.1 India Companion Diagnostics Market by Cancer Type
5.4 Australia Companion Diagnostics Market
5.4.1 Australia Companion Diagnostics Market by Technology
5.4.2 Australia Companion Diagnostics Market by Indication
5.4.2.1 Australia Companion Diagnostics Market by Cancer Type
5.5 South Korea Companion Diagnostics Market
5.5.1 South Korea Companion Diagnostics Market by Technology
5.5.2 South Korea Companion Diagnostics Market by Indication
5.5.2.1 South Korea Companion Diagnostics Market by Cancer Type
5.6 Singapore Companion Diagnostics Market
5.6.1 Singapore Companion Diagnostics Market by Technology
5.6.2 Singapore Companion Diagnostics Market by Indication
5.6.2.1 Singapore Companion Diagnostics Market by Cancer Type
5.7 Rest of Asia Pacific Companion Diagnostics Market
5.7.1 Rest of Asia Pacific Companion Diagnostics Market by Technology
5.7.2 Rest of Asia Pacific Companion Diagnostics Market by Indication
5.7.2.1 Rest of Asia Pacific Companion Diagnostics Market by Cancer Type
CHAPTER 6. COMPANY PROFILES
6.1 Agilent Technologies, Inc.
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 Recent strategies and developments:
6.1.5.1 Product launches:
6.1.5.2 Expansions:
6.2 Almac Group
6.2.1 Company Overview
6.2.1 Recent strategies and developments:
6.2.1.1 Collaborations, partnerships and agreements:
6.3 ARUP Laboratories, Inc.
6.3.1 Company Overview
6.4 Abbott Laboratories (Abbott Laboratories Molecular, Inc.)
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expense
6.5 Danaher Corporation
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental and Regional Analysis
6.5.4 Research & Development Expense
6.5.5 Recent strategies and developments:
6.5.5.1 Acquisition and mergers:
6.6 Thermo Fischer Scientific, Inc.
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expense
6.6.5 Recent strategies and developments:
6.6.5.1 Collaborations, partnerships and agreements:
6.6.5.2 Expansions:
6.7 Hologic, Inc.
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Segmental and Regional Analysis
6.7.4 Research & Development Expense
6.7.5 Recent strategies and developments:
6.7.5.1 Product launches:
6.7.5.2 Acquisition and mergers:
6.8 Novartis AG
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental and Regional Analysis
6.8.4 Research & Development Expense
6.8.5 Recent strategies and developments:
6.8.5.1 Collaborations, partnerships and agreements:
6.9 Illumina, Inc.
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Regional Analysis
6.9.4 Research & Development Expense
6.9.5 Recent strategies and developments:
6.9.5.1 Product launches:
6.9.5.2 Acquisition and mergers:
6.9.5.3 Collaborations, partnerships and agreements:
6.1 Qiagen N.V.
6.10.1 Company Overview
6.10.2 Financial Analysis
6.10.3 Regional Analysis
6.10.4 Research & Development Expense
6.10.5 Recent strategies and developments:
6.10.5.1 Product launches:
6.10.5.2 Collaborations, partnerships and agreements:
LIST OF TABLES
TABLE 1 ASIA PACIFIC COMPANION DIAGNOSTICS MARKET, 2015 - 2018, USD MILLION
TABLE 2 ASIA PACIFIC COMPANION DIAGNOSTICS MARKET, 2019 - 2025, USD MILLION
TABLE 3 ASIA PACIFIC COMPANION DIAGNOSTICS MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 4 ASIA PACIFIC COMPANION DIAGNOSTICS MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 5 ASIA PACIFIC IMMUNOHISTOCHEMISTRY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 6 ASIA PACIFIC IMMUNOHISTOCHEMISTRY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 7 ASIA PACIFIC POLYMERASE CHAIN REACTION (PCR) MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 8 ASIA PACIFIC POLYMERASE CHAIN REACTION (PCR) MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 9 ASIA PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 10 ASIA PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 11 ASIA PACIFIC IN SITU HYBRIDIZATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 12 ASIA PACIFIC IN SITU HYBRIDIZATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 13 ASIA PACIFIC OTHER TECHNOLOGY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 14 ASIA PACIFIC OTHER TECHNOLOGY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 15 ASIA PACIFIC COMPANION DIAGNOSTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
TABLE 16 ASIA PACIFIC COMPANION DIAGNOSTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
TABLE 17 ASIA PACIFIC ONCOLOGY COMPANION DIAGNOSTICS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 18 ASIA PACIFIC ONCOLOGY COMPANION DIAGNOSTICS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 19 ASIA PACIFIC COMPANION DIAGNOSTICS MARKET BY CANCER TYPE, 2015 - 2018, USD MILLION
TABLE 20 ASIA PACIFIC COMPANION DIAGNOSTICS MARKET BY CANCER TYPE, 2019 - 2025, USD MILLION
TABLE 21 ASIA PACIFIC BREAST CANCER COMPANION DIAGNOSTICS BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 22 ASIA PACIFIC BREAST CANCER COMPANION DIAGNOSTICS BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 23 ASIA PACIFIC COLORECTAL CANCER COMPANION DIAGNOSTICS BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 24 ASIA PACIFIC COLORECTAL CANCER COMPANION DIAGNOSTICS BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 25 ASIA PACIFIC LUNG CANCER COMPANION DIAGNOSTICS BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 26 ASIA PACIFIC LUNG CANCER COMPANION DIAGNOSTICS BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 27 ASIA PACIFIC BLOOD CANCER COMPANION DIAGNOSTICS BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 28 ASIA PACIFIC BLOOD CANCER COMPANION DIAGNOSTICS BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 29 ASIA PACIFIC OTHER CANCER TYPE COMPANION DIAGNOSTICS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 30 ASIA PACIFIC OTHER CANCER TYPE COMPANION DIAGNOSTICS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 31 ASIA PACIFIC NEUROLOGY COMPANION DIAGNOSTICS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 32 ASIA PACIFIC NEUROLOGY COMPANION DIAGNOSTICS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 33 ASIA PACIFIC OTHER INDICATIONS COMPANION DIAGNOSTICS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 34 ASIA PACIFIC OTHER INDICATIONS COMPANION DIAGNOSTICS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 35 ASIA PACIFIC COMPANION DIAGNOSTICS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 36 ASIA PACIFIC COMPANION DIAGNOSTICS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 37 CHINA COMPANION DIAGNOSTICS MARKET, 2015 - 2018, USD MILLION
TABLE 38 CHINA COMPANION DIAGNOSTICS MARKET, 2019 - 2025, USD MILLION
TABLE 39 CHINA COMPANION DIAGNOSTICS MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 40 CHINA COMPANION DIAGNOSTICS MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 41 CHINA COMPANION DIAGNOSTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
TABLE 42 CHINA COMPANION DIAGNOSTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
TABLE 43 CHINA COMPANION DIAGNOSTICS MARKET BY CANCER TYPE, 2015 - 2018, USD MILLION
TABLE 44 CHINA COMPANION DIAGNOSTICS MARKET BY CANCER TYPE, 2019 - 2025, USD MILLION
TABLE 45 JAPAN COMPANION DIAGNOSTICS MARKET, 2015 - 2018, USD MILLION
TABLE 46 JAPAN COMPANION DIAGNOSTICS MARKET, 2019 - 2025, USD MILLION
TABLE 47 JAPAN COMPANION DIAGNOSTICS MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 48 JAPAN COMPANION DIAGNOSTICS MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 49 JAPAN COMPANION DIAGNOSTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
TABLE 50 JAPAN COMPANION DIAGNOSTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
TABLE 51 JAPAN COMPANION DIAGNOSTICS MARKET BY CANCER TYPE, 2015 - 2018, USD MILLION
TABLE 52 JAPAN COMPANION DIAGNOSTICS MARKET BY CANCER TYPE, 2019 - 2025, USD MILLION
TABLE 53 INDIA COMPANION DIAGNOSTICS MARKET, 2015 - 2018, USD MILLION
TABLE 54 INDIA COMPANION DIAGNOSTICS MARKET, 2019 - 2025, USD MILLION
TABLE 55 INDIA COMPANION DIAGNOSTICS MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 56 INDIA COMPANION DIAGNOSTICS MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 57 INDIA COMPANION DIAGNOSTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
TABLE 58 INDIA COMPANION DIAGNOSTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
TABLE 59 INDIA COMPANION DIAGNOSTICS MARKET BY CANCER TYPE, 2015 - 2018, USD MILLION
TABLE 60 INDIA COMPANION DIAGNOSTICS MARKET BY CANCER TYPE, 2019 - 2025, USD MILLION
TABLE 61 AUSTRALIA COMPANION DIAGNOSTICS MARKET, 2015 - 2018, USD MILLION
TABLE 62 AUSTRALIA COMPANION DIAGNOSTICS MARKET, 2019 - 2025, USD MILLION
TABLE 63 AUSTRALIA COMPANION DIAGNOSTICS MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 64 AUSTRALIA COMPANION DIAGNOSTICS MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 65 AUSTRALIA COMPANION DIAGNOSTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
TABLE 66 AUSTRALIA COMPANION DIAGNOSTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
TABLE 67 AUSTRALIA COMPANION DIAGNOSTICS MARKET BY CANCER TYPE, 2015 - 2018, USD MILLION
TABLE 68 AUSTRALIA COMPANION DIAGNOSTICS MARKET BY CANCER TYPE, 2019 - 2025, USD MILLION
TABLE 69 SOUTH KOREA COMPANION DIAGNOSTICS MARKET, 2015 - 2018, USD MILLION
TABLE 70 SOUTH KOREA COMPANION DIAGNOSTICS MARKET, 2019 - 2025, USD MILLION
TABLE 71 SOUTH KOREA COMPANION DIAGNOSTICS MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 72 SOUTH KOREA COMPANION DIAGNOSTICS MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 73 SOUTH KOREA COMPANION DIAGNOSTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
TABLE 74 SOUTH KOREA COMPANION DIAGNOSTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
TABLE 75 SOUTH KOREA COMPANION DIAGNOSTICS MARKET BY CANCER TYPE, 2015 - 2018, USD MILLION
TABLE 76 SOUTH KOREA COMPANION DIAGNOSTICS MARKET BY CANCER TYPE, 2019 - 2025, USD MILLION
TABLE 77 SINGAPORE COMPANION DIAGNOSTICS MARKET, 2015 - 2018, USD MILLION
TABLE 78 SINGAPORE COMPANION DIAGNOSTICS MARKET, 2019 - 2025, USD MILLION
TABLE 79 SINGAPORE COMPANION DIAGNOSTICS MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 80 SINGAPORE COMPANION DIAGNOSTICS MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 81 SINGAPORE COMPANION DIAGNOSTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
TABLE 82 SINGAPORE COMPANION DIAGNOSTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
TABLE 83 SINGAPORE COMPANION DIAGNOSTICS MARKET BY CANCER TYPE, 2015 - 2018, USD MILLION
TABLE 84 SINGAPORE COMPANION DIAGNOSTICS MARKET BY CANCER TYPE, 2019 - 2025, USD MILLION
TABLE 85 REST OF ASIA PACIFIC COMPANION DIAGNOSTICS MARKET, 2015 - 2018, USD MILLION
TABLE 86 REST OF ASIA PACIFIC COMPANION DIAGNOSTICS MARKET, 2019 - 2025, USD MILLION
TABLE 87 REST OF ASIA PACIFIC COMPANION DIAGNOSTICS MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 88 REST OF ASIA PACIFIC COMPANION DIAGNOSTICS MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 89 REST OF ASIA PACIFIC COMPANION DIAGNOSTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
TABLE 90 REST OF ASIA PACIFIC COMPANION DIAGNOSTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
TABLE 91 REST OF ASIA PACIFIC COMPANION DIAGNOSTICS MARKET BY CANCER TYPE, 2015 - 2018, USD MILLION
TABLE 92 REST OF ASIA PACIFIC COMPANION DIAGNOSTICS MARKET BY CANCER TYPE, 2019 - 2025, USD MILLION
TABLE 93 KEY INFORMATION – AGILENT TECHNOLOGIES, INC.
TABLE 94 KEY INFORMATION – ALMAC GROUP
TABLE 95 KEY INFORMATION – ARUP LABORATORIES, INC.
TABLE 96 KEY INFORMATION – ABBOTT LABORATORIES
TABLE 97 KEY INFORMATION – DANAHER CORPORATION
TABLE 98 KEY INFORMATION – THERMO FISHER SCIENTIFIC, INC.
TABLE 99 KEY INFORMATION – HOLOGIC, INC.
TABLE 100 KEY INFORMATION – NOVARTIS AG
TABLE 101 KEY INFORMATION – ILLUMINA, INC.
TABLE 102 KEY INFORMATION – QIAGEN N.V.
TABLE 1 ASIA PACIFIC COMPANION DIAGNOSTICS MARKET, 2015 - 2018, USD MILLION
TABLE 2 ASIA PACIFIC COMPANION DIAGNOSTICS MARKET, 2019 - 2025, USD MILLION
TABLE 3 ASIA PACIFIC COMPANION DIAGNOSTICS MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 4 ASIA PACIFIC COMPANION DIAGNOSTICS MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 5 ASIA PACIFIC IMMUNOHISTOCHEMISTRY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 6 ASIA PACIFIC IMMUNOHISTOCHEMISTRY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 7 ASIA PACIFIC POLYMERASE CHAIN REACTION (PCR) MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 8 ASIA PACIFIC POLYMERASE CHAIN REACTION (PCR) MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 9 ASIA PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 10 ASIA PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 11 ASIA PACIFIC IN SITU HYBRIDIZATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 12 ASIA PACIFIC IN SITU HYBRIDIZATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 13 ASIA PACIFIC OTHER TECHNOLOGY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 14 ASIA PACIFIC OTHER TECHNOLOGY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 15 ASIA PACIFIC COMPANION DIAGNOSTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
TABLE 16 ASIA PACIFIC COMPANION DIAGNOSTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
TABLE 17 ASIA PACIFIC ONCOLOGY COMPANION DIAGNOSTICS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 18 ASIA PACIFIC ONCOLOGY COMPANION DIAGNOSTICS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 19 ASIA PACIFIC COMPANION DIAGNOSTICS MARKET BY CANCER TYPE, 2015 - 2018, USD MILLION
TABLE 20 ASIA PACIFIC COMPANION DIAGNOSTICS MARKET BY CANCER TYPE, 2019 - 2025, USD MILLION
TABLE 21 ASIA PACIFIC BREAST CANCER COMPANION DIAGNOSTICS BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 22 ASIA PACIFIC BREAST CANCER COMPANION DIAGNOSTICS BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 23 ASIA PACIFIC COLORECTAL CANCER COMPANION DIAGNOSTICS BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 24 ASIA PACIFIC COLORECTAL CANCER COMPANION DIAGNOSTICS BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 25 ASIA PACIFIC LUNG CANCER COMPANION DIAGNOSTICS BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 26 ASIA PACIFIC LUNG CANCER COMPANION DIAGNOSTICS BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 27 ASIA PACIFIC BLOOD CANCER COMPANION DIAGNOSTICS BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 28 ASIA PACIFIC BLOOD CANCER COMPANION DIAGNOSTICS BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 29 ASIA PACIFIC OTHER CANCER TYPE COMPANION DIAGNOSTICS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 30 ASIA PACIFIC OTHER CANCER TYPE COMPANION DIAGNOSTICS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 31 ASIA PACIFIC NEUROLOGY COMPANION DIAGNOSTICS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 32 ASIA PACIFIC NEUROLOGY COMPANION DIAGNOSTICS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 33 ASIA PACIFIC OTHER INDICATIONS COMPANION DIAGNOSTICS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 34 ASIA PACIFIC OTHER INDICATIONS COMPANION DIAGNOSTICS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 35 ASIA PACIFIC COMPANION DIAGNOSTICS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 36 ASIA PACIFIC COMPANION DIAGNOSTICS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 37 CHINA COMPANION DIAGNOSTICS MARKET, 2015 - 2018, USD MILLION
TABLE 38 CHINA COMPANION DIAGNOSTICS MARKET, 2019 - 2025, USD MILLION
TABLE 39 CHINA COMPANION DIAGNOSTICS MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 40 CHINA COMPANION DIAGNOSTICS MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 41 CHINA COMPANION DIAGNOSTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
TABLE 42 CHINA COMPANION DIAGNOSTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
TABLE 43 CHINA COMPANION DIAGNOSTICS MARKET BY CANCER TYPE, 2015 - 2018, USD MILLION
TABLE 44 CHINA COMPANION DIAGNOSTICS MARKET BY CANCER TYPE, 2019 - 2025, USD MILLION
TABLE 45 JAPAN COMPANION DIAGNOSTICS MARKET, 2015 - 2018, USD MILLION
TABLE 46 JAPAN COMPANION DIAGNOSTICS MARKET, 2019 - 2025, USD MILLION
TABLE 47 JAPAN COMPANION DIAGNOSTICS MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 48 JAPAN COMPANION DIAGNOSTICS MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 49 JAPAN COMPANION DIAGNOSTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
TABLE 50 JAPAN COMPANION DIAGNOSTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
TABLE 51 JAPAN COMPANION DIAGNOSTICS MARKET BY CANCER TYPE, 2015 - 2018, USD MILLION
TABLE 52 JAPAN COMPANION DIAGNOSTICS MARKET BY CANCER TYPE, 2019 - 2025, USD MILLION
TABLE 53 INDIA COMPANION DIAGNOSTICS MARKET, 2015 - 2018, USD MILLION
TABLE 54 INDIA COMPANION DIAGNOSTICS MARKET, 2019 - 2025, USD MILLION
TABLE 55 INDIA COMPANION DIAGNOSTICS MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 56 INDIA COMPANION DIAGNOSTICS MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 57 INDIA COMPANION DIAGNOSTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
TABLE 58 INDIA COMPANION DIAGNOSTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
TABLE 59 INDIA COMPANION DIAGNOSTICS MARKET BY CANCER TYPE, 2015 - 2018, USD MILLION
TABLE 60 INDIA COMPANION DIAGNOSTICS MARKET BY CANCER TYPE, 2019 - 2025, USD MILLION
TABLE 61 AUSTRALIA COMPANION DIAGNOSTICS MARKET, 2015 - 2018, USD MILLION
TABLE 62 AUSTRALIA COMPANION DIAGNOSTICS MARKET, 2019 - 2025, USD MILLION
TABLE 63 AUSTRALIA COMPANION DIAGNOSTICS MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 64 AUSTRALIA COMPANION DIAGNOSTICS MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 65 AUSTRALIA COMPANION DIAGNOSTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
TABLE 66 AUSTRALIA COMPANION DIAGNOSTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
TABLE 67 AUSTRALIA COMPANION DIAGNOSTICS MARKET BY CANCER TYPE, 2015 - 2018, USD MILLION
TABLE 68 AUSTRALIA COMPANION DIAGNOSTICS MARKET BY CANCER TYPE, 2019 - 2025, USD MILLION
TABLE 69 SOUTH KOREA COMPANION DIAGNOSTICS MARKET, 2015 - 2018, USD MILLION
TABLE 70 SOUTH KOREA COMPANION DIAGNOSTICS MARKET, 2019 - 2025, USD MILLION
TABLE 71 SOUTH KOREA COMPANION DIAGNOSTICS MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 72 SOUTH KOREA COMPANION DIAGNOSTICS MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 73 SOUTH KOREA COMPANION DIAGNOSTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
TABLE 74 SOUTH KOREA COMPANION DIAGNOSTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
TABLE 75 SOUTH KOREA COMPANION DIAGNOSTICS MARKET BY CANCER TYPE, 2015 - 2018, USD MILLION
TABLE 76 SOUTH KOREA COMPANION DIAGNOSTICS MARKET BY CANCER TYPE, 2019 - 2025, USD MILLION
TABLE 77 SINGAPORE COMPANION DIAGNOSTICS MARKET, 2015 - 2018, USD MILLION
TABLE 78 SINGAPORE COMPANION DIAGNOSTICS MARKET, 2019 - 2025, USD MILLION
TABLE 79 SINGAPORE COMPANION DIAGNOSTICS MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 80 SINGAPORE COMPANION DIAGNOSTICS MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 81 SINGAPORE COMPANION DIAGNOSTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
TABLE 82 SINGAPORE COMPANION DIAGNOSTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
TABLE 83 SINGAPORE COMPANION DIAGNOSTICS MARKET BY CANCER TYPE, 2015 - 2018, USD MILLION
TABLE 84 SINGAPORE COMPANION DIAGNOSTICS MARKET BY CANCER TYPE, 2019 - 2025, USD MILLION
TABLE 85 REST OF ASIA PACIFIC COMPANION DIAGNOSTICS MARKET, 2015 - 2018, USD MILLION
TABLE 86 REST OF ASIA PACIFIC COMPANION DIAGNOSTICS MARKET, 2019 - 2025, USD MILLION
TABLE 87 REST OF ASIA PACIFIC COMPANION DIAGNOSTICS MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 88 REST OF ASIA PACIFIC COMPANION DIAGNOSTICS MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 89 REST OF ASIA PACIFIC COMPANION DIAGNOSTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
TABLE 90 REST OF ASIA PACIFIC COMPANION DIAGNOSTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
TABLE 91 REST OF ASIA PACIFIC COMPANION DIAGNOSTICS MARKET BY CANCER TYPE, 2015 - 2018, USD MILLION
TABLE 92 REST OF ASIA PACIFIC COMPANION DIAGNOSTICS MARKET BY CANCER TYPE, 2019 - 2025, USD MILLION
TABLE 93 KEY INFORMATION – AGILENT TECHNOLOGIES, INC.
TABLE 94 KEY INFORMATION – ALMAC GROUP
TABLE 95 KEY INFORMATION – ARUP LABORATORIES, INC.
TABLE 96 KEY INFORMATION – ABBOTT LABORATORIES
TABLE 97 KEY INFORMATION – DANAHER CORPORATION
TABLE 98 KEY INFORMATION – THERMO FISHER SCIENTIFIC, INC.
TABLE 99 KEY INFORMATION – HOLOGIC, INC.
TABLE 100 KEY INFORMATION – NOVARTIS AG
TABLE 101 KEY INFORMATION – ILLUMINA, INC.
TABLE 102 KEY INFORMATION – QIAGEN N.V.
LIST OF FIGURES
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 1 METHODOLOGY FOR THE RESEARCH
